Explore 3 Stock Ideas & Industry Insights Download Free Report

Clover Corporation Ltd

Company price
1.015 AUD -0.02 ( 1.93%)
Last update at 2026-11-06T05:10:00Z
VOLUME
51177
Market Cap
172.84M
P/E
17.25

Momentum Score

…

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.99
Low
1.04
High
52 Week Price Range
0.64
Low
1.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Clover Corporation is an Australian specialty ingredient company that produces medium-chain triglyceride (MCT) oils and other specialty lipids for food, beverage and nutraceutical applications. Long-term growth drivers include rising consumer demand for ketogenic and functional nutrition, expanding global markets for specialty lipids, and product differentiation in higher-margin ingredient categories. The company may benefit from exposure to health-focused ingredient trends and established manufacturing capabilities.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.03
Dividend Yield
2.30%
Revenue TTM
97.41M
Revenue Per Share
0.58
Gross Profit TTM
34.62M
Debt / Equity
0.01
ROE
13.93%
Net Debt
-6.15M
ROCE
20.69%
Diluted EPS TTM
0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-07-31 2025-07-31 2024-07-31 2023-07-31 2022-07-31
Type yearly yearly yearly yearly yearly
Date 2026-07-31 2025-07-31 2024-07-31 2023-07-31 2022-07-31
Income before tax 15.50M 10.44M 1.86M 8.36M 9.84M
Net income 10.46M 7.01M 1.51M 6.21M 7.13M
Selling general administrative - 7.61M 5.56M 5.51M 4.56M
Selling and marketing expenses - 5.58M 4.82M 5.69M 4.00M
Gross profit 33.97M 26.17M 16.86M 23.74M 21.53M
Reconciled depreciation - 1.56M 1.17M 0.92M 0.71M
Ebit 16.35M 10.68M 2.82M 9.09M 10.29M
Ebitda 17.78M 12.24M 3.98M 10.01M 11.01M
Depreciation and amortization 1.43M 1.56M 1.17M 0.92M 0.71M
Operating income 16.35M 8.33M 3.07M 9.09M 10.29M
Other operating expenses 81.06M 77.67M 59.03M 71.51M 60.26M
Interest expense 0.04M 0.24M 0.90M 0.73M 0.46M
Tax provision - 3.42M 0.40M 2.16M 2.71M
Interest income - 0.54M 1.21M 1.22M 1.11M
Net interest income - -0.24M -0.90M -0.73M -0.46M
Income tax expense 5.05M 3.42M 0.40M 2.16M 2.71M
Total revenue 97.41M 86.00M 62.21M 79.88M 70.66M
Total operating expenses 17.62M 17.84M 14.90M 15.37M 11.13M
Cost of revenue 63.44M 59.83M 45.34M 56.14M 49.13M
Total other income expense net -0.84M 2.10M -1.21M -0.19M -0.46M
Net income from continuing ops - 7.01M 1.51M 6.21M 7.13M
Net income applicable to common shares - 7.01M 1.51M 6.21M 7.13M
Breakdown 2026-07-31 2025-07-31 2024-07-31 2023-07-31 2022-07-31
Type yearly yearly yearly yearly yearly
Date 2026-07-31 2025-07-31 2024-07-31 2023-07-31 2022-07-31
Total assets 97.76M 86.80M 84.39M 86.20M 90.60M
Other current assets 1.53M - - 1.74M 1.22M
Total liab 19.80M 14.57M 17.32M 19.05M 27.56M
Total stockholder equity 77.96M 72.23M 67.07M 67.15M 63.04M
Other current liab 8.42M - - 2.20M 6.43M
Common stock 36.27M - - 36.27M 35.60M
Capital stock - 36.27M 36.27M 36.27M 35.60M
Retained earnings 43.11M 35.88M 32.00M 31.74M 28.45M
Other liab - - - 1.18M 0.02M
Good will 1.91M 1.91M 1.91M 1.91M 1.91M
Other assets - - - 1.29M 0.84M
Cash 7.22M 8.68M 12.26M 9.44M 10.11M
Total current liabilities 18.75M 12.68M 9.83M 8.29M 17.25M
Net debt -6.15M - - 2.27M 1.97M
Short term debt 0.40M - - 2.13M 1.78M
Short long term debt - 0.92M 3.44M 1.74M 1.67M
Short long term debt total 1.07M - - 11.71M 12.08M
Other stockholder equity - - - -0.19M -1.01M
Property plant equipment - - - 11.34M 9.18M
Total current assets 69.96M 59.03M 56.88M 60.01M 66.86M
Long term investments - 11.33M 11.25M 11.66M 11.82M
Net tangible assets - - - 65.24M 61.13M
Net receivables 17.27M 23.47M 12.00M 11.95M 19.56M
Long term debt - - 5.03M 7.69M 9.24M
Inventory 43.95M 24.14M 29.55M 36.88M 35.97M
Accounts payable 9.93M 6.12M 5.08M 3.96M 9.04M
Accumulated other comprehensive income -1.42M - - -0.85M -1.01M
Non current assets total 27.80M 27.77M 27.51M 26.20M 23.74M
Capital lease obligations - 1.50M 1.92M 2.28M 1.17M
Long term debt total - - - 9.58M 10.30M
Breakdown 2026-07-31 2025-07-31 2024-07-31 2023-07-31 2022-07-31
Type yearly yearly yearly yearly yearly
Date 2026-07-31 2025-07-31 2024-07-31 2023-07-31 2022-07-31
Investments - -1.34M -2.97M -2.53M -1.60M
Change to liabilities - - - -8.69M 0.07M
Total cashflows from investing activities -0.46M -1.34M -2.97M -2.53M -1.60M
Net borrowings - -7.57M -5.97M -1.96M -2.30M
Total cash from financing activities -5.40M -10.52M -2.66M -4.88M -3.96M
Change to operating activities - - - 1.48M 1.97M
Net income 10.46M 7.01M 1.51M 6.21M 7.13M
Change in cash -1.47M -3.58M 2.82M -0.67M 1.02M
Begin period cash flow 8.68M 12.26M 9.44M 10.11M 9.09M
End period cash flow 7.22M 8.68M 12.26M 9.44M 10.11M
Total cash from operating activities 4.39M 8.29M 8.45M 6.74M 7.84M
Depreciation 1.43M - 1.17M 0.81M 0.71M
Other cashflows from investing activities - 0.00M -0.36M -0.89M -0.89M
Dividends paid 3.34M -2.50M -1.25M -2.92M -1.66M
Change to inventory -19.81M 5.41M 7.32M -0.91M -5.19M
Change to account receivables 6.71M -11.40M -1.76M 7.61M -6.30M
Sale purchase of stock -0.70M - - - -
Other cashflows from financing activities -0.44M -0.45M 4.56M -0.23M -0.13M
Change to netincome - - - 0.19M 0.41M
Capital expenditures 1.07M 1.34M 2.33M 1.64M 1.60M
Change in working capital -9.20M 0.50M 5.80M -0.73M -0.46M
Stock based compensation - - 0.04M - -
Other non cash items 1.70M 7.78M -0.07M - -7.84M
Free cash flow 3.32M 6.95M 6.13M -1.64M 6.25M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CLV
Clover Corporation Ltd
-0.02
1.93%
1.01 17.25 26.18 1.77 2.14 1.65 9.48
A2M
The a2 Milk Company Ltd
-0.13
1.79%
7.13 29.04 28.74 2.68 5.94 2.85 17.82
BGA
Bega Cheese Ltd
0.02
0.31%
6.43 35.61 22.94 0.52 1.93 0.60 11.82
CBO
Cobram Estate Olives Ltd
-
-%
2.70 - - 4.79 2.48 6.63 185.44
RIC
Ridley Corporation Ltd
-
-%
2.68 38.29 13.42 0.35 2.01 0.53 4.50

Profile*

Clover Corporation Ltd

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

39 Pinnacle Road, Altona North, VIC, Australia, 3025

61 3 8347 5000

81

Name Title Year Born
Mr. Peter J. Davey GAICD, gradDip Bus., MBA CEO, MD & Exec. Director NA
Mr. Andrew G. M. Allibon C.A. CFO & Company Sec. NA
Mr. David Pierotti Operations Mang. NA
Mr. Timothy Murphy Human Resource & Payroll Mang. NA
S. Poothong Chief Commercial Officer NA
Mr. Peter J. Davey GAICD, gradDip Bus., MBA CEO, MD & Executive Director NA
Mr. Andrew G. M. Allibon C.A. CFO & Company Secretary NA
Mr. David Pierotti Director of Operations NA
Mr. Bassam Hallak Director of Sales & Marketing NA
Ms. Anne Roach General Manager of People & Culture NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…